Advertisement
Imaging
Subscribe to Imaging
View Sample

FREE Email Newsletter

Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2011 Financial Results

November 8, 2010 3:35 am | by Bio-Medicine.Org | News | Comments

BETHESDA, Md., Nov. 8, 2010 /PRNewswire-Asia/ -- Chindex International, Inc. (Nasdaq: CHDX ), a leading independent American provider of Western healthcare products and services in the People's Republic of China, today announced financial results for the second quarter and first half of...

Parascript Awarded $244,479.25 Affordable Care Act Grant From the U.S. Government

November 8, 2010 3:35 am | by Bio-Medicine.Org | News | Comments

LONGMONT, Colo., Nov. 8, 2010 /- Parascript, LLC, the image analysis and pattern recognition technology provider, today announced that it was awarded a cash grant of $244,479.25 under the U.S. Government's Affordable Care Act. Under this act, the therapeutic discovery project program...

Need Help Affording Your Meds? LegitScript Adds Patient Assistance Feature

November 7, 2010 10:32 pm | by Bio-Medicine.Org | News | Comments

PORTLAND, Oregon, Nov. 8, 2010 /- A leading Internet pharmacy verification service offers a new message for patients: There are ways to get affordable medicines without using unregulated, potentially dangerous "rogue" Internet pharmacies. LegitScript, a firm that monitors "rogue" Internet...

Advertisement

WuXi PharmaTech Awarded GLP Certificate from SFDA for Suzhou Toxicology Facility

November 7, 2010 10:32 pm | by Bio-Medicine.Org | News | Comments

SHANGHAI, Nov. 8, 2010 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX ), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced that it had been awarded a Certificate of Good...

Chimerix Reaffirms Its Commitment to CMX001 as a Medical Countermeasure for Smallpox and Broad-Spectrum Antiviral Agent

November 7, 2010 8:35 pm | by Bio-Medicine.Org | News | Comments

RESEARCH TRIANGLE PARK, N.C., Nov. 7, 2010 /- Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, today reaffirmed its commitment to the dual development of CMX001 as a medical countermeasure against smallpox and as a broad-spectrum antiviral...

In First Phase 3 Trial, Tasocitinib (CP-690,550), an Oral JAK Inhibitor, Administered as Monotherapy, Reduces Signs and Symptoms of Active Rheumatoid Arthritis and Improves Ph...

November 7, 2010 4:33 pm | by Bio-Medicine.Org | News | Comments

NEW YORK, Nov. 7, 2010 /- Pfizer Inc. (NYSE: PFE ) today announced results of ORAL Solo (1045), a Phase 3 study that showed tasocitinib (CP-690,550), an investigational, novel, oral JAK inhibitor, administered as monotherapy met two primary endpoints, demonstrating a statistically...

Medicare Policy Changes Will Make it More Difficult for Nevada Beneficiaries to Obtain Power Wheelchairs

November 5, 2010 12:35 pm | by Bio-Medicine.Org | News | Comments

RENO, Nev., Nov. 5, 2010 /PRNewswire-USNewswire/ -- Will power wheelchairs continue to be available to Nevada's Medicare patients following a series of federal regulatory and policy changes? There are grave concerns among consumer groups, Medicare beneficiaries and homecare equipment...

Dehaier Medical Wins $2 Million Distribution Bid for Rural Healthcare Construction Project

November 5, 2010 7:39 am | by Bio-Medicine.Org | News | Comments

BEIJING, Nov. 5, 2010 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM ) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that it has won a...

Advertisement

SAFE IN COMMON Launches Global Injection Safety Website

November 5, 2010 7:39 am | by Bio-Medicine.Org | News | Comments

LEWISBERRY, Pa., Nov. 5, 2010 /- SAFE IN COMMON, an online community of  healthcare workers, educators, patients, community leaders and individuals, today announced the launch of its website dedicated to raising awareness of global injection safety challenges. SAFE IN COMMON's launch...

IntegenX Launches the Apollo 324 System for Automated DNA Library Preparation at the ASHG Meeting

November 5, 2010 7:39 am | by Bio-Medicine.Org | News | Comments

PLEASANTON, Calif., Nov. 5, 2010 /- IntegenX, Inc. (IXI) today at the 60th Annual American Society of Human Genetics Meeting announced the launch of their Apollo 324™ System, a benchtop robotic workstation that automates the construction of DNA fragment libraries for next-generation...

Varian Medical Systems Management to Present at Lazard Capital Markets 7th Annual Healthcare Conference

November 5, 2010 7:38 am | by Bio-Medicine.Org | News | Comments

PALO ALTO, Calif., Nov. 5, 2010 /- Varian Medical Systems (NYSE: VAR ) is scheduled to present at Lazard Capital Markets Healthcare Conference at 9:30 a.m. ET on Wednesday, November 17th at the St. Regis Hotel in New York City. Participating executives will include Elisha Finney, senior...

Business-to-Business Magazine Names Orion HealthCorp CEO as Top 25 Entrepreneur for 2010

November 4, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

ATLANTA, Nov. 4, 2010 /- Orion HealthCorp , Inc., a leader in medical billing and practice management for more than 20 years, announced today that its President and CEO, Terrence L. Bauer, has been named to Business-to-Business Magazine's 2010 Top 25 Entrepreneur list. Bauer ranked No. 12...

SPO Announces Completion of Rebranding Program

November 4, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

SPO Announces Completion of Rebranding Program -- NEW YORK, November 4, 2010 /-

Advertisement

Valeant Pharmaceuticals Reports 2010 Third Quarter Financial Results

November 4, 2010 3:35 am | by Bio-Medicine.Org | News | Comments

MISSISSAUGA, Ontario, Nov. 4, 2010 /- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) (TSX: VRX) announces third quarter financial results for 2010. The merger of Biovail Corporation (Legacy Biovail) and Valeant Pharmaceuticals International (Legacy Valeant) was completed on...

Valeant Declares Special Dividend and Plans to Create a Special Dividend Reinvestment Plan

November 4, 2010 3:34 am | by Bio-Medicine.Org | News | Comments

MISSISSAUGA, Ontario, Nov. 4, 2010 /- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) (TSX: VRX) today announced that the Company's Board of Directors (the "Board") has declared a one-time special dividend of US$1.00 per common share (the "Special Dividend") that shareholders of...

Stereotaxis Awarded $1.5 Million in Grants under the Qualifying Therapeutic Discovery Project Program

November 4, 2010 3:34 am | by Bio-Medicine.Org | News | Comments

ST. LOUIS, Nov. 4, 2010 /- Stereotaxis, Inc. (Nasdaq: STXS ) announced today that it has been awarded $1.5 million in grants under the Qualifying Therapeutic Discovery Project Program that was enacted under the Patient Protection and Affordable Care Act of 2010.  The program targets...

Interventional Spine®, Inc. Announces Issuance of Key Patents for the PERPOS® PLS System

November 4, 2010 3:34 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Nov. 4, 2010 /- Interventional Spine®, Inc. today announced that the United States Patent Office has issued U.S. Patent No. 7,824,429, entitled Method and Apparatus for Spinal Fixation.  This patent includes 43 claims that provide key patent protection for the...

Cocrystal Discovery Receives Awards for Its Novel Antiviral Drug Development Programs

November 3, 2010 10:34 am | by Bio-Medicine.Org | News | Comments

SEATTLE, Nov. 3, 2010 /- Cocrystal Discovery, Inc., a biopharmaceutical company focused on the discovery and development of novel antiviral therapeutics for the treatment of serious and chronic viral diseases, announced today that it has received $733,438 in grants from the Qualified...

PhRMA CEO John Castellani Responds to Mid-Term Election, Stresses Importance of Innovation to Help Grow Economy

November 3, 2010 10:34 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, Nov. 3, 2010 /PRNewswire-USNewswire/ -- Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John Castellani released the following statement and video regarding the mid-term election: Watch the Video "Congratulations to all of the candidates who...

Research Facility Expansion Will Create, Retain More than 150 Jobs in Chester County

November 3, 2010 10:34 am | by Bio-Medicine.Org | News | Comments

HARRISBURG, Pa., Nov. 3, 2010 /PRNewswire-USNewswire/ -- A global contract research organization will expand its operations in Chester County and create more than 80 new jobs within three years, the Department of Community and Economic Development announced today. PPD Inc. is planning to...

IRS Awards $244,479 Grant to STB Lifesaving Technologies®

November 3, 2010 10:34 am | by Bio-Medicine.Org | News | Comments

ROCKVILLE, Md., Nov. 3, 2010 /- STB Lifesaving Technologies ® today announced that it has been awarded a Qualifying Therapeutic Discovery Project (QTDP) grant from the U.S. government in the amount of $244,479.   The Qualifying Therapeutic Discovery Project was included in the...

Regado Biosciences to Present at the IMPACT 2010 Conference in Philadelphia, Pennsylvania

November 3, 2010 10:34 am | by Bio-Medicine.Org | News | Comments

BASKING RIDGE, N.J., Nov. 3, 2010 /- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced that Ellen McDonald, MBA, Senior Vice President and Chief Business Officer, will be presenting at IMPACT 2010 held at...

Champions Biotechnology Awarded $1.46 million in Grants

November 3, 2010 10:34 am | by Bio-Medicine.Org | News | Comments

BALTIMORE, Nov. 3, 2010 /- Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR ), a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, today received $1.46 million in grants as part of the Qualifying...

ACR Distributes Free High-Tech Mammography Education Tool to NY Facilities

November 3, 2010 10:33 am | by Bio-Medicine.Org | News | Comments

RESTON, Va., Nov. 3, 2010 /PRNewswire-USNewswire/ -- The American College of Radiology (ACR) distributed 1,500 copies of the College's Mammography Case Review ( MCR5 ) educational CD-ROM free of charge to physicians in approximately 600 ACR-accredited mammography facilities throughout New...

Asia Pacific Pharma Companies Turning to High-Risk, High-Reward Drug Development, According to New Report from Thomson Reuters

November 2, 2010 11:33 pm | by Bio-Medicine.Org | News | Comments

PHILADELPHIA and LONDON, Nov. 3, 2010 /- Pharmaceutical companies in the Asia Pacific region are increasingly adapting their business models from the production of generic drugs towards more high-risk, high-return research and development, according to a new report released today by CMR...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading